Associate Director, International Market Access & Pricing – Neuroscience, Migraine

This position supports the Director, International Market Access & Pricing – Migraine, in developing access strategies and key deliverables for the Prevention of Migraine and Menstrual Migraine indications. For the prevention indication, the focus will be on partnering with Area and Affiliate teams to secure access in markets where it has not yet been achieved and to improve access where Aquipta has already launched. The Menstrual Migraine indication represents an exciting new chapter for Aquipta; here, the role will focus on launch preparation, working with cross-functional teams on launch strategy, launch readiness and the approach to securing access. • This role will leverage your clinical understanding, deep global payer knowledge and competitive insights to shape Access deliverables for Aquipta (atogepant). • The position works closely with Area and Affiliate teams to determine appropriate responses and actions at key development milestones, with regard to their implications for local pricing and reimbursement. • The primary goal of this position is to define and refine the international pricing and access strategy, and to influence the global commercial strategy and integrated evidence programme, in order to optimise price, reimbursement and patient access for Aquipta. Overall Responsibilities Include: • Assessing and addressing pricing, reimbursement and access (PRA) potential across key international markets, including the EU5, Canada, Japan, Australia, Brazil and China • Co-leading, with the Director, International Market Access & Pricing – Migraine, the Value and Access Team (VAT) through the creation and roll-out of the Integrated Access Strategy (IAS) for Menstrual Migraine, leveraging evidence-based medicine expertise, clinical background, deep global payer knowledge, research and competitive insights • Working with cross-functional stakeholders, such as IMCO, Medical Affairs and Government Affairs, to shape the brand plan, and acting as a key contributor to an AbbVie migraine platform launching in 2027 • Updating international access materials (e.g. IAS, value proposition, payer objection handler and negotiation pathway) based on market insights and competitor dynamics • Collaborating with other iMAP functions, such as Pricing and HTA Strategy, as well as GHEOR, MABI, Government Affairs, IMCO, Pipeline Commercial Development, Medical Affairs and complementary Area and Affiliate functions, to ensure a solid understanding of global payer markets and emerging reimbursement stakeholders • Leading project management, including purchasing support and the opening of POs, and ensuring appropriate project documentation is in place and stored in line with company procedures • More than 7 years of direct biotechnology / pharmaceutical industry experience and/or payer experience • Strong interest in clinical and health economic data • Proven track record of interacting successfully with all levels of Area, Affiliate and internal leadership across divisions (including Global Commercial Leaders, Forecasting, Clinical Development, HEOR, Medical Affairs and Regulatory), as well as with peers in other market access teams and the wider market access community • Strong leadership, interpersonal, critical thinking and analytical skills, with the ability to work across a variety of groups to ensure the strategic direction for market access and pricing balances market realities with corporate goals • Sensitivity to cultural and market differences, as the role involves interacting with, and travelling to, multiple countries • Relevant global payer and access experience • Education: Bachelor’s degree required; an advanced degree (e.g. PharmD, MBA, PhD) in a scientific or economic discipline is desirable   Preferred Qualifi